Abstract
Introduction
Worldwide breast cancer (BC) is the most common cancer of women. 1 Bangladesh. 2 BC patients may experience multiple symptoms at a time due to the disease itself, treatment or combination of both. 3 e study follows de nitions of 'symptoms' and 'clustered symptoms' after a literature review. Subjective perception of disease is known as "symptom". 1,2 Symptoms may be complex and clustered in nature. 3 Aggregations of three or more symptoms that may or may not be originated from a single source are known as "clustered symptoms". Su erings due to multiple symptoms are a source of reduced quality of life and functional status in patients with breast cancer. Previous studies have found that symptoms of fatigue, depression, sleep disturbances and pain are prevalent across di erent stages of breast cancer and treatment. 2, [4] [5] [6] [7] [8] Symptoms such as pain, fatigue, sleep alterations, depression, loss of appetite were identi ed by previous studies as most common, associated or highly prevalent symptoms of breast cancer patients. 1, 8 Symptom clusters may a ect each other and may trigger other symptoms to a ect QOL. 3, 9, 10 Identi cation of meaningful subgroups of patients within this disease/particular to the disease is therefore important as these groups may represent di erent aetiological and pathophysiological entities and they may require di erent treatment approaches. [9] [10] [11] Symptom clusters in Bangladeshi women with breast cancer are little known. e aim of this study was to investigate the existence of natural symptom clusters of women with breast cancer systematically.
Methods
is was a retrospective observational study. Hospital notes and case sheets were screened to identify patients with breast cancer primary breast cancer patients registered with the Centre for Palliative Care (CPC) over a ve-year period between January 2009 and December 2013), in the only medical university in Bangladesh to include in the study.
e inclusion criteria were women aged 18 years or above diagnosed with breast cancer of any stage with or without ongoing de nitive treatment. Exclusion criteria included a past medical history of cancer or immune-related disease (i.e. multiple sclerosis, HIV, lupus) or not having a histopathologically con rmed breast malignancy.
At the time of rst consultation patients demographic and other symptoms were documented after thorough assessment of the patient in a case sheet with a total of 91 variables (22 demographic and 69 clinical) by a team that include one medical doctor with six weeks training in palliative medicine and one nurse trained in six weeks palliative nursing. e university institutional review board approved this study.
Analyses were carried out using SPSS. Baseline data were analyzed using parametric statistics and are expressed as mean values. Pearson correlation coe cients were used to explore linear relationships between di erent continuous variables.
A hierarchical cluster analysis was used to classify data based on variables according to physical and psychological symptoms.
is method is explanatory and we had no preconceived ideas about how variables would cluster together. Euclidean distance measure was used in the process. Similar symptoms were put by the technique into the same group in a hierarchical way, so that most similar two symptoms are rst put into a group. e algorithm iteratively estimates the cluster means and assigns each variable to the cluster.
e validity of the three subgroups solution was explored by comparing subgroup membership across physical and psychological symptom measures, using ANOVA. Signi cance was de ned as p<0.05.
Results
A total of 120 case sheets of carcinoma breast patients were selected for this study. Among those case sheets 8 were discarded because the patients did not have any histopathological evidence on admission.
ese patients underwent FNAC after admission to have diagnosis. Data are therefore presented on 112 patients.
ere was no signi cant di erence in baseline measures of physical, psychological symptoms or demographic variables between those patients whose case sheets were discarded for this study. e initial dataset included 120 subjects ranging in age from 17 to 80 years. Complementary therapy was taken by 40 (35.7) patients, which include Ayurveda, homeopathy or religious approach. Among the patients, 93 (83%) of the patients had de nitive therapy. Forty-seven patients (44%) had emotional problems. e most common conditions were depression, n=28 (28%) and anxiety states, n=32 (30%).
Time since diagnosis to rst consultation ranged from 3 days to 143 months, with a mean of 25 months (SD=25.3). Time since diagnosis to death ranged from 8 days to 145 months, with a mean of 28 months (SD=27.67). Almost 39 percent of the women had breast cancer stage II or over with a missing value of 37.5%. Other clinical characteristics are summarized in Table-I & Table- II. Signi cant medium correlation between pain with weakness and anxiety, large correlation between nausea with loss of appetite and a large correlation was found with weakness and sleeplessness. Other signi cant correlations are shown in table -III.
Hierarchical cluster analysis grouped together related symptoms, based on the observed similarities between them. Using the agglomerative cluster approach, a dendrogram was generated. Figure-1 shows the total process of joining individual points to one big cluster.
Figure -1: Results of cluster analysis
sleeplessness and loss of appetite. is cluster was named as "neuro-psychiatric' symptom cluster. e symptoms in cluster 2 comprised cough, breathlessness, nausea and constipation.
is cluster was named as 'respiratorygastrointestinal' symptom cluster. Cluster 3 consisted of two symptoms lymphedema and sadness and this was named as 'miscellaneous' symptom cluster.
A one-way between-groups multivariate analysis of variance was performed to investigate cluster di erences in physical and psychological symptoms. Pain, nausea, loss of appetite, constipation, weakness, cough, breathlessness, sleeplessness, lymphoedema, anxiety, depression and sadness were used as dependent variables. e independent variable was group containing three clusters. Preliminary assumption testing was conducted to check for normality, linearity, univariate and multivariate outliers, homogeneity of variancecovariance matrices, multicollinearity, with no serious violations noted.
ere was a statistically signi cant di erence between group 1, group 2 and group 3 on the combined dependent variables, F (11, 11) = 2.76, p = .011; Wilks' Lambda = .07; partial eta squared = .95. When the results for the dependent variables were considered separately, di erences to reach statistical signi cance, using a Bonferroni adjusted alpha levels of .302, .412 and .20, was weakness, F (2, 21) = 5.98, p = .009, partial eta squared = .36; sleeplessness F (2, 21) = 9.05, p = .001, partial eta squared = .46 and lymphedema F (2, 21) = 4.00, p = .03, partial eta squared = .27. An inspection of the mean pain scores indicated that cluster 1 had slightly lower levels of pain (C1 = .78, SD = .44) than other two groups (C2 = 1.00, SD = .00) & (C3 = 1.00, SD = .00). (Table-IV e results of cluster analysis with matrix of association coe cients between individual symptoms are shown in Table 3 . Pain, depression and anxiety were associated most closely.
e association coe cient between pain and depression, anxiety and weakness was .917, .875 and .708. Furthermore, weakness and sleeplessness formed a relatively tight cluster with a distance of .875. Loss of appetite was joined next to this cluster, with an association coe cient of .625.
e next symptoms included in this cluster were cough, breathlessness, nausea and constipation.
us we could identify three symptom clusters. Cluster 1 was characterized by pain, depression, anxiety, weakness,
Discussion
ere are several important ndings derived from this retrospective analysis that may be used to inform future studies. We chose a set of symptom clusters of pain, nausea, loss of appetite, constipation, weakness, cough, breathlessness, sleeplessness, lymphedema, sadness, anxiety and depression based on previous literature. Denie e et al undertook a prospective longitudinal study to discover the symptoms of breast cancer before surgical intervention and also to know the impact of these symptoms on ninety four patients. 9, [11] [12] [13] [14] [15] [16] It was found that 35% of the females with BC had pain, 32% had fatigue, sleep disturbances a ected 25.5% and 11% had depression. Quality of life was measured with Hospital Anxiety and Depression Scale, Insomnia Severity Index, Functional Assessment of Cancer erapy-Fatigue; and Brief Pain Inventory and European Organization for research and treatment. Fatigue showed a moderate correlation with emotional functioning and a weak correlation with physical and social functioning. A secondary analysis of 128 women with breast cancer (Stages I-II) was undertaken at 4 weeks after lumpectomy or mastectomy, before receiving their rst dose of chemotherapy.
is time point was selected because it provided an adequate duration of time after surgery for return of baseline immune parameters.
ey chose a well-described symptom cluster of fatigue, depression, pain and sleep disturbance, a majority of the sample had very low symptom scores for both pain and sleep disturbances. In our study, about 77 (68.8%) of the participants had undergone surgery, 88 (78.6%) had completed or undergoing chemotherapy schedules and 60 (53.6%) had radiotherapy. We found that pain (76.8%) had the highest scores among all symptoms.
We excluded symptoms with extremely low scores. Although pain was measured with the numerical scale, other symptoms were not measured with any measurement scale.
erefore we could not assign any clinical signi cant cut-o score for each symptom, however we decided to include the symptoms according to their scores to increase the homogeneity of the sample in terms of their symptom experience. We decided to include symptoms which had scores >20%.
Another study with a total of 320 women with breast cancer undergoing chemotherapy were ranged in age from 17 to 68 years, with a mean of 47.3 years (SD= 8.8), majority had stage II breast cancer. [17] [18] [19] [20] is study revealed that symptom clusters were not identical across symptom dimensions. In addition, symptom clusters revealed in this study are more likely treatment-related symptom clusters, particularly gastrointestinal and fatigue related symptoms. Gastrointestinal symptoms (such as nausea, vomiting, lack of appetite) and fatigue related symptoms were reported as common adverse e ects of the standard chemotherapy regimen using the combination of cyclophosphamide, methotrexate, 5-FU, and doxorubicin. Gastrointestinal and [21] [22] [23] [24] Our study identi ed neuro-psychiatric and weakness as clusters in breast cancer patients. e ndings from this study supported previous studies that symptom clusters existed in this group of women across cultural studies. e di erences in the structures of symptom clustering might be from the di erences between the sample characteristics or the methodology used in each study.
ere are three major limitations of the study. Firstly, approximately 40% of the case sheets did not include ECOG measurements. Although they appeared similar to those who had ECOG grades in terms of gastrointestinal symptoms and psychological pro le, subtle di erences cannot be excluded. Secondly, the study was carried out in a tertiary centre and therefore the nding should not be generalized to primary care or community subjects with carcinoma breast. irdly, all the symptoms were not measured using reliable and validated scales. e drawback of this is that we have failed to recognize clinical details that might be added to the research. e way forward may be to target to develop speci c treatments for subgroups. e current study provided empirical evidence that Bangladeshi breast cancer patients experience multiple symptom clusters. Future study could be done to verify these three symptom clusters and identify underlying mechanism.
e ndings suggested that these women experienced multidimensional symptoms together that were interrelated and aggregated in three major groups. Health professionals could pay more attention to more speci c assessment and management to these patients.
